RSS

DSS Document Security Systems

Last Post: 07/31/23
Followers: 10
Posts Today: 0
Views Today: 155

DSS Stock Quote & Tools

$0.6140 ▲ +0.0103 (+1.71%) As of Oct 16, 9:46 AM EDT
Last0.6140
$ Chg0.0103
Open0.6037
High0.6140
Beta1.0366
Year High1.860
Market Cap6.17M
P/B Ratio-15.91
EPS-2.95
Avg Vol (30d)4.09M
Volume917
% Chg+1.71%
Prev Close0.6037
Low0.6037
VWAP0.60858
Year Low0.361
Total Shares10.04M
Shares Out10.04M
Float3.90M
ExchangeNYSE American
Consumer Discretionary Containers & Packaging

DSS Stock Message Board Discussion

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Market Expansion of Utility Solar Trackers: Future Insights

Updated Category News Views 247

Utility Solar Tracker Market Growth Prospects The utility solar tracker market is projected to reach an impressive USD 34.6 billion in the coming years. This growth is largely driven by the declining costs of photovoltaic (PV) panels, which have significantly lowered the financial barriers for solar energy projects. As PV panels become more affordable, the opportunity for...

Continue Reading
UVA Cancer Center Joins Caris Precision Oncology Alliance

Updated Category News Views 59

UVA Cancer Center Joins the Caris Precision Oncology Alliance UVA Cancer Center has officially joined the Caris Precision Oncology Alliance (Caris POA), a significant network dedicated to advancing precision medicine and cancer treatment. Caris Life Sciences is thrilled to welcome this esteemed institution, recognized for its commitment to enhancing patient outcomes...

Continue Reading
Investors Show Strong Confidence in Spotify Technology's Future Potential

Updated Category News Views 116

High-Rolling Investors Stake Their Bets on Spotify Technology In recent developments, it's evident that significant investors have adopted a bullish stance on Spotify Technology. This movement warrants attention from retail traders and those interested in stock market dynamics. Overview of Options Activity Tracking the latest trends, we've noted a remarkable surge in...

Continue Reading
Johnson & Johnson's Groundbreaking CAR T-Cell Therapy Data Unveiled

Updated Category News Views 191

Johnson & Johnson’s CAR T-Cell Therapy Demonstrates Promise in Lymphoma In a recent Phase 1b study, Johnson & Johnson (NYSE: JNJ) revealed the first clinical results of its investigational dual-targeting CAR T-cell therapy, JNJ-90014496, specifically aimed at treating patients with relapsed or refractory large B-cell lymphoma (R/R LBCL). This early data suggests a...

Continue Reading
Booking Holdings Prepares for Upcoming Earnings Report

Updated Category News Views 143

Booking Holdings Set for Earnings Announcement Booking Holdings (NASDAQ: BKNG) is gearing up to share its quarterly earnings. Investors are keenly awaiting this announcement, which is expected to be significant for market sentiment and share price movements. Expected Earnings Per Share According to analysts, Booking Holdings is projected to report an impressive earnings...

Continue Reading